Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Bonora

Showing results (71-80 of 302) with videos related to

Pageof 31
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|March 19, 2010
HPLC-MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditionsAntonio D'Avolio, Marco Simiele, Marco Siccardi, et al.
International Journal of STD & AIDS|October 11, 2021
Efflorescence of acquired epidermodysplasia verruciformis due to immune reconstitution inflammatory syndrome-like mechanisms following anti-HPV vaccination in a HIV-positive patientMichele Parietti, Mattia Trunfio, Sergio Delmonte, et al.
Biomedical Optics Express|March 18, 2015
In vivo imaging of human photoreceptor mosaic with wavefront sensorless adaptive optics optical coherence tomographyKevin S K Wong, Yifan Jian, Michelle Cua, et al.
Diagnostic Microbiology and Infectious Disease|March 30, 2019
Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate are not transported by Concentrative Nucleoside Transporter 2Jessica Cusato, Andrea Calcagno, Amedeo De Nicolò, et al.
Interactive Cardiovascular and Thoracic Surgery|February 12, 2013
Experimental evaluation of a new system for laser tissue welding applied on damaged lungsMarco Schiavon, Giuseppe Marulli, Andrea Zuin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 28, 2009
Tenofovir coadministration is not associated with lower unboosted atazanavir plasma exposure in the clinical settingAndrea Calcagno, Stefano Bonora, Maria Cristina Tettoni, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 19, 2003
HIV-1 phenotypic susceptibility to lopinavir (LPV) and genotypic analysis in LPV/r-naive subjects with prior protease inhibitor experienceLaura Monno, Annalisa Saracino, Luigia Scudeller, et al.
Antimicrobial Agents and Chemotherapy|October 18, 2002
Lopinavir measurement in pleural effusion in a human immunodeficiency virus type 1-infected patient with kaposi's sarcomaMarta Boffito, Patrick G Hoggard, David J Back, et al.
Therapeutic Drug Monitoring|October 1, 2008
An HPLC-PDA method for the simultaneous quantification of the HIV integrase inhibitor raltegravir, the new nonnucleoside reverse transcriptase inhibitor etravirine, and 11 other antiretroviral agents in the plasma of HIV-infected patientsAntonio D'Avolio, Lorena Baietto, Marco Siccardi, et al.
Therapeutic Drug Monitoring|December 31, 2009
A validated high-performance liquid chromatography-ultraviolet method for quantification of the CCR5 inhibitor maraviroc in plasma of HIV-infected patientsAntonio D'Avolio, Marco Simiele, Lorena Baietto, et al.
Pageof 31

Showing results (71-80 of 302) with videos related to

Sort By:
Pageof 31
Journal of Pharmaceutical and Biomedical Analysis|March 19, 2010
HPLC-MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditionsAntonio D'Avolio, Marco Simiele, Marco Siccardi, et al.
International Journal of STD & AIDS|October 11, 2021
Efflorescence of acquired epidermodysplasia verruciformis due to immune reconstitution inflammatory syndrome-like mechanisms following anti-HPV vaccination in a HIV-positive patientMichele Parietti, Mattia Trunfio, Sergio Delmonte, et al.
Biomedical Optics Express|March 18, 2015
In vivo imaging of human photoreceptor mosaic with wavefront sensorless adaptive optics optical coherence tomographyKevin S K Wong, Yifan Jian, Michelle Cua, et al.
Diagnostic Microbiology and Infectious Disease|March 30, 2019
Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate are not transported by Concentrative Nucleoside Transporter 2Jessica Cusato, Andrea Calcagno, Amedeo De Nicolò, et al.
Interactive Cardiovascular and Thoracic Surgery|February 12, 2013
Experimental evaluation of a new system for laser tissue welding applied on damaged lungsMarco Schiavon, Giuseppe Marulli, Andrea Zuin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 28, 2009
Tenofovir coadministration is not associated with lower unboosted atazanavir plasma exposure in the clinical settingAndrea Calcagno, Stefano Bonora, Maria Cristina Tettoni, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 19, 2003
HIV-1 phenotypic susceptibility to lopinavir (LPV) and genotypic analysis in LPV/r-naive subjects with prior protease inhibitor experienceLaura Monno, Annalisa Saracino, Luigia Scudeller, et al.
Antimicrobial Agents and Chemotherapy|October 18, 2002
Lopinavir measurement in pleural effusion in a human immunodeficiency virus type 1-infected patient with kaposi's sarcomaMarta Boffito, Patrick G Hoggard, David J Back, et al.
Therapeutic Drug Monitoring|October 1, 2008
An HPLC-PDA method for the simultaneous quantification of the HIV integrase inhibitor raltegravir, the new nonnucleoside reverse transcriptase inhibitor etravirine, and 11 other antiretroviral agents in the plasma of HIV-infected patientsAntonio D'Avolio, Lorena Baietto, Marco Siccardi, et al.
Therapeutic Drug Monitoring|December 31, 2009
A validated high-performance liquid chromatography-ultraviolet method for quantification of the CCR5 inhibitor maraviroc in plasma of HIV-infected patientsAntonio D'Avolio, Marco Simiele, Lorena Baietto, et al.
Pageof 31